Last Updated: October 3, 2025
Analyzing Management
Public company leadership serves as a crucial variable for hedge funds and asset managers during both initial due diligence and continuous risk assessment. ManagementTrack offers a systematic approach that eliminates distractions by highlighting distinct strengths and weaknesses, identifying warning signs and positive indicators, and drawing a clear connection between CEO actions and investment performance.
CEO McNamara’s M&A skill may not offset weak growth and compliance risks.
Analysis of Chemed CEO Kevin McNamara
While possessing strategic M&A experience, Kevin McNamara’s past compliance issues and weak organic growth execution leave him neutrally positioned to manage Chemed’s critical operational pivots and regulatory risks.
Management evaluated Kevin McNamara’s track record and skillset against the following key factors for CHE:
- Ramping Up New VITAS Markets to Build a Medicare Cap Buffer.
- Accelerating Roto-Rooter’s Pivot to High-Value Services.
- Stabilizing Roto-Rooter Margins Amidst Competitive Pressure.
- Containing the $19M VITAS Florida Medicare Cap Liability.
Kevin McNamara’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
As VITAS expands to mitigate Medicare Cap pressure, will McNamara prioritize aggressive growth and admissions, or will he enforce the disciplined compliance and risk oversight that was absent during the period leading to the $75M DOJ settlement?
Question #2
Given the persistent margin pressure and organic growth challenges at Roto-Rooter, will McNamara demonstrate the operational focus required to execute a turnaround, or will he revert to his playbook of relying on M&A and portfolio-level strategy to drive value?
Why Do Investors Use ManagementTrack?
Q: How does ManagementTrack assess Kevin McNamara at CHE?
A: ManagementTrack leverages its proprietary career analysis and interviews with former colleagues to establish a track record, identify key strengths and weaknesses, and then evaluate those attributes against CHE’s critical challenges: ramping up new VITAS markets, accelerating Roto-Rooter’s shift to high-value services, stabilizing Roto-Rooter’s margins, and containing the VITAS Florida Medicare cap liability.
Q: Beyond individual executive analysis, what other methods does ManagementTrack use to predict company performance?
A: ManagementTrack utilizes proprietary models to detect when executive evasion in earnings call Q&A becomes abnormal. It also examines all insider trading activity to pinpoint outlier transactions that can predict future stock movements. Paired with the ManagementTrack Rating, a predictive 1-10 score assigned to every executive, these tools give investors a definitive positive or negative outlook on how leadership capabilities will influence future company performance.
Q: What is the scope of ManagementTrack’s coverage?
A: ManagementTrack delivers real-time coverage for the c-suite of every public company.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
Verified Career History by ManagementTrack for Kevin McNamara
Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
Chemed Corp. 10Q
Chemed Corp. 10K
Chemed Corp. Earnings Calls
Chemed Corp. Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
